Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.42 | N/A |
| PEG Ratio (TTM) | 0.07 | N/A |
| P/S Ratio (TTM) | 0.29 | N/A |
| P/B Ratio (TTM) | 1.04 | N/A |
| P/FCF Ratio (TTM) | 4.35 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.48 | N/A |
| Price to 5YR AVG FCF Ratio | 4.70 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.35% | N/A |
| ROE (TTM) | 6.88% | N/A |
| Net Profit Margin (TTM) | 1.87% | N/A |
| ROIC 5YR AVG | 11.15% | N/A |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 56.79% | 65.39% | 94.99% |
| Revenue | -1.23% | 36.22% | 21.82% |
| Net Income | 57.57% | 68.59% | 103.67% |
| Cash Flow | 22.97% | 15.11% | 486.03% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.99 | N/A |
| Quick Ratio (TTM) | 0.99 | N/A |
| D/E Ratio (TTM) | 1.50 | N/A |
| Interest Coverage (TTM) | 1.54 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.89 | N/A |
| LTL to 5YR AVG FCF | 6.10 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.36% | N/A |